On day 3 following lithium-pilocarpine administration (compared with controls), the only indicated pathways were those relevant to Huntington’s disease, TNF signaling, NF-kappa B signaling, etc., however, there were no more than four proteins in each pathway. This evidence concerns the gene TNF and juvenile Huntington disease.